Free-cash-flow proxy increased 45.0%
Free-cash-flow proxy changed +45.0% from the comparable as-filed period.
$39.2M→$56.9M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TTAN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 43.8%
Operating cash flow changed +43.8% from the comparable as-filed period.
$40.3M→$58.0M3 prior comparisons
Operating margin moved 495 bp higher
Operating margin changed +495 basis points from the comparable as-filed period.
-14.36%→-9.41%2 prior comparisons
Research & development increased 37.7%
Research & development changed +37.7% from the comparable as-filed period.
$73.1M→$100.6M2 prior comparisons
Revenue increased 20.9%
Revenue changed +20.9% from the comparable as-filed period.
$242.1M→$292.8M2 prior comparisons
Trade receivables increased 34.7%
Trade receivables changed +34.7% from the comparable as-filed period.
$51.9M→$69.9M3 prior comparisons
Operating income increased 20.8%
Operating income changed +20.8% from the comparable as-filed period.
-$34.8M→-$27.6M2 prior comparisons
Net income increased 22.7%
Net income changed +22.7% from the comparable as-filed period.
-$32.2M→-$24.9M2 prior comparisons
Gross profit increased 22.0%
Gross profit changed +22.0% from the comparable as-filed period.
$171.3M→$209.1M2 prior comparisons
Free-cash-flow margin moved 323 bp higher
Free-cash-flow margin changed +323 basis points from the comparable as-filed period.
16.20%→19.43%2 prior comparisons
Operating cash-flow margin moved 315 bp higher
Operating cash-flow margin changed +315 basis points from the comparable as-filed period.
16.66%→19.81%2 prior comparisons
Gross margin moved 64 bp higher
Gross margin changed +64 basis points from the comparable as-filed period.
70.77%→71.41%2 prior comparisons
Stock-based compensation increased 22.9%
Stock-based compensation changed +22.9% from the comparable as-filed period.
$49.3M→$60.6M2 prior comparisons
Receivables / revenue moved 244 bp higher
Receivables / revenue changed +244 basis points from the comparable as-filed period.
21.43%→23.87%2 prior comparisons
R&D / revenue moved 420 bp higher
R&D / revenue changed +420 basis points from the comparable as-filed period.
30.18%→34.37%2 prior comparisons
Working capital increased 8.0%
Working capital changed +8.0% from the comparable as-filed period.
$484.2M→$522.9M3 prior comparisons
Current assets increased 7.6%
Current assets changed +7.6% from the comparable as-filed period.
$623.0M→$670.4M3 prior comparisons
Working capital / assets moved 184 bp higher
Working capital / assets changed +184 basis points from the comparable as-filed period.
27.15%→28.98%3 prior comparisons
Capex / revenue moved 8 bp lower
Capex / revenue changed -8 basis points from the comparable as-filed period.
0.46%→0.38%2 prior comparisons
Current liabilities increased 6.3%
Current liabilities changed +6.3% from the comparable as-filed period.
$138.7M→$147.5M3 prior comparisons
Total assets increased 1.1%
Total assets changed +1.1% from the comparable as-filed period.
$1.8B→$1.8B3 prior comparisons
SBC / revenue moved 33 bp higher
SBC / revenue changed +33 basis points from the comparable as-filed period.
20.36%→20.69%2 prior comparisons
Cash & equivalents increased 1.7%
Cash & equivalents changed +1.7% from the comparable as-filed period.
$471.5M→$479.5M2 prior comparisons
Current ratio increased 1.2%
Current ratio changed +1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.49→4.553 prior comparisons
Capital expenditure decreased 0.2%
Capital expenditure changed -0.2% from the comparable as-filed period.
$1.1M→$1.1M3 prior comparisons
Free-cash-flow proxy increased 86.4%
Free-cash-flow proxy changed +86.4% from the comparable as-filed period.
-$15.9M→-$2.2M2 prior comparisons
Gross margin moved 329 bp higher
Gross margin changed +329 basis points from the comparable as-filed period.
68.80%→72.09%2 prior comparisons
Operating income increased 48.0%
Operating income changed +48.0% from the comparable as-filed period.
-$49.5M→-$25.8M2 prior comparisons
Operating cash flow increased 89.3%
Operating cash flow changed +89.3% from the comparable as-filed period.
-$14.6M→-$1.6M2 prior comparisons
Operating margin moved 1338 bp higher
Operating margin changed +1338 basis points from the comparable as-filed period.
-22.97%→-9.58%2 prior comparisons
Net income increased 50.8%
Net income changed +50.8% from the comparable as-filed period.
-$46.4M→-$22.8M2 prior comparisons
Revenue increased 24.6%
Revenue changed +24.6% from the comparable as-filed period.
$215.7M→$268.8M2 prior comparisons
Gross profit increased 30.6%
Gross profit changed +30.6% from the comparable as-filed period.
$148.4M→$193.8M2 prior comparisons
Research & development increased 27.3%
Research & development changed +27.3% from the comparable as-filed period.
$69.1M→$88.0M2 prior comparisons
Trade receivables increased 37.7%
Trade receivables changed +37.7% from the comparable as-filed period.
$46.0M→$63.4M2 prior comparisons
Free-cash-flow margin moved 655 bp higher
Free-cash-flow margin changed +655 basis points from the comparable as-filed period.
-7.35%→-0.80%2 prior comparisons
Operating cash-flow margin moved 617 bp higher
Operating cash-flow margin changed +617 basis points from the comparable as-filed period.
-6.76%→-0.58%2 prior comparisons
Stock-based compensation increased 24.7%
Stock-based compensation changed +24.7% from the comparable as-filed period.
$43.7M→$54.6M2 prior comparisons
Current liabilities increased 17.9%
Current liabilities changed +17.9% from the comparable as-filed period.
$114.8M→$135.4M2 prior comparisons
Capital expenditure decreased 53.9%
Capital expenditure changed -53.9% from the comparable as-filed period.
$1.3M→$596,0002 prior comparisons
Receivables / revenue moved 224 bp higher
Receivables / revenue changed +224 basis points from the comparable as-filed period.
21.33%→23.57%2 prior comparisons
Current assets increased 8.7%
Current assets changed +8.7% from the comparable as-filed period.
$553.0M→$600.9M2 prior comparisons
Stockholders' equity increased 7.3%
Stockholders' equity changed +7.3% from the comparable as-filed period.
$1.5B→$1.6B2 prior comparisons
Working capital increased 6.2%
Working capital changed +6.2% from the comparable as-filed period.
$438.1M→$465.5M2 prior comparisons
Capex / revenue moved 38 bp lower
Capex / revenue changed -38 basis points from the comparable as-filed period.
0.60%→0.22%2 prior comparisons
Working capital / assets moved 127 bp higher
Working capital / assets changed +127 basis points from the comparable as-filed period.
25.36%→26.64%2 prior comparisons
Current ratio decreased 7.9%
Current ratio changed -7.9% from the comparable as-filed period.
4.82→4.442 prior comparisons
Total assets increased 1.2%
Total assets changed +1.2% from the comparable as-filed period.
$1.7B→$1.7B2 prior comparisons
SBC / revenue moved 2 bp higher
SBC / revenue changed +2 basis points from the comparable as-filed period.
20.28%→20.30%2 prior comparisons
R&D / revenue moved 69 bp higher
R&D / revenue changed +69 basis points from the comparable as-filed period.
32.05%→32.74%2 prior comparisons
Cash & equivalents increased 0.3%
Cash & equivalents changed +0.3% from the comparable as-filed period.
$420.3M→$421.5M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.